INFU InfuSystem Holdings, Inc.: Nilai perusahaan marang pendapatan

Simbol resmi perusahaan InfuSystem Inc (INFU)

Reliance on long-term contracts with oncology centers and an extensive equipment fleet supports margin growth as InfuSystem Holdings (INFU) scales its business. The EV-to-revenue ratio clearly demonstrates this trend, where 2042.79 captures the current state of the parameter. High cash flow predictability, driven by recurring pump rental payments and the sale of consumables, completes the picture.

InfuSystem (INFU): Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

INFU (InfuSystem): rincian analitis lan laporan miturut indikator

- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi saham perusahaan:
Pambiji fundamental perusahaan:INFU (InfuSystem Inc)
Produk sing diprodhuksi InfuSystem Holdings, Inc.

Fundamental asset selection requires analyzing business value while accounting for debt load. This indicator compares the enterprise value (EV) of a company to its annual revenue, eliminating the influence of capital structure. For InfuSystem Holdings (INFU), this metric confirms the efficiency of pump fleet management and the transparency of long-term contracts. A stable EV-to-revenue ratio demonstrates the business's actual margin of safety. The trend in the EV-to-revenue level helps distinguish resilience from capital stagnation.

Analisis pesaing

ISRG - Multiplikator EV/Sales|DHR: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan BD (BDX)|Rasio nilai perusahaan marang pendapatan STERIS plc|Rasio nilai perusahaan marang pendapatan WST (West Pharmaceutical Services)|Nilai perusahaan marang pendapatan BAX (Baxter Corp)|Masimo - Rasio nilai perusahaan marang pendapatan|Stevanato Group S.p.A. - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Teleflex Inc (TFX)|MMSI - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Envista Holdings Corp NVST|ICUI: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan XRAY|LMAT (LeMaitre Corp) - Multiplikator EV/Sales|ATRC (AtriCure Inc) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales STAA|NAGE (ChromaDex Corp) - Nilai bisnis marang pendapatan|ZimVie Inc. - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan angiodynamics.com (ANGO)|CERS - Rasio nilai perusahaan marang pendapatan|TKNO - Multiplikator EV/Sales|Monogram Technologies Inc (MGRM) - Rasio nilai perusahaan marang pendapatan|STSS - Rasio total nilai perusahaan marang pendapatan|UTMD (Utah Medical Products Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan KORU Medical Systems KRMD|Rasio nilai perusahaan marang pendapatan Nyxoah SA (NYXH)|Koefisien nilai perusahaan marang pendapatan MBOT|Multiplikator EV/Sales PDEX (Pro-Dex Inc.)|Koefisien nilai perusahaan marang pendapatan ZTEK (Zentek Limited)|elutia.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Nilai perusahaan marang pendapatan|Retractable Technologies - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan harvardbioscience.com|Femasys Corp (FEMY) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales MHUA|Predictive Oncology Inc. - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales CJMB (Callan JMB Inc)|Multiplikator EV/Sales Atrion Corp ATRI|NeuroMetrix Corporation - Multiplikator EV/Sales